Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant therapy with pembrolizumab in renal cell carcinoma: real-world experiences from a retrospective, multi-institutional cohort.
Mattigk A, Cano Garcia C, Klümper N, Cox A, Hahn O, Junker K, Erdmann K, Schmucker P, Flegar L, Zengerling F, Banek S, Ellinger J, Buerk BT, Huber J, Kalogirou C, Zeuschner P, Hoeh B. Mattigk A, et al. Among authors: ellinger j. Urol Int. 2024 Dec 24:1-21. doi: 10.1159/000543278. Online ahead of print. Urol Int. 2024. PMID: 39719131
High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial.
Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, Breyer J, Darr C, Dressler FF, Ellinger J, Erber R, Esposito I, Hartmann A, Hartmann W, Heitplatz B, Kreipe H, Lafos M, Linxweiler J, Lopez-Cotarelo C, Sailer V, Reis H, Saar M, Schildhaus HU, Schlack K, Schmid M, Seidl M, Semjonow A, Sommer U, Stahl PR, Tischler V, Weber F, Wulf AL, Wullich B, Kristiansen G. Hommerding O, et al. Among authors: ellinger j. Virchows Arch. 2024 Dec 9. doi: 10.1007/s00428-024-03999-y. Online ahead of print. Virchows Arch. 2024. PMID: 39653828
Ultra-high gradient performance 3-Tesla MRI for super-fast and high-quality prostate imaging: initial experience.
Bischoff LM, Endler C, Krausewitz P, Ellinger J, Klümper N, Isaak A, Mesropyan N, Kravchenko D, Nowak S, Kuetting D, Sprinkart AM, Mürtz P, Pieper CC, Attenberger U, Luetkens JA. Bischoff LM, et al. Among authors: ellinger j. Insights Imaging. 2024 Nov 29;15(1):287. doi: 10.1186/s13244-024-01862-x. Insights Imaging. 2024. PMID: 39614012 Free PMC article.
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial.
Al-Monajjed R, Albers P, Droop J, Fugmann D, Noldus J, Palisaar RJ, Ritter M, Ellinger J, Krausewitz P, Truß M, Hadaschik B, Grünwald V, Schrader AJ, Papavassilis P, Ernstmann N, Schellenberger B, Moritz A, Kowalski C, Hellmich M, Heiden P, Hagemeier A, Horenkamp-Sonntag D, Giessing M, Pauler L, Dieng S, Peters M, Feick G, Karger A; PRO-P study group. Al-Monajjed R, et al. Among authors: ellinger j. Trials. 2024 Nov 12;25(1):754. doi: 10.1186/s13063-024-08579-8. Trials. 2024. PMID: 39533412 Free PMC article.
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.
Hommerding M, Hommerding O, Bernhardt M, Kreft T, Sanders C, Tischler V, Basitta P, Pelusi N, Wulf AL, Ohlmann CH, Ellinger J, Ritter M, Kristiansen G. Hommerding M, et al. Among authors: ellinger j. World J Urol. 2024 Aug 22;42(1):491. doi: 10.1007/s00345-024-05188-7. World J Urol. 2024. PMID: 39172235 Free PMC article.
First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany.
Cano Garcia C, Hoeh B, Mandal S, Banek S, Klümper N, Schmucker P, Hahn O, Mattigk A, Ellinger J, Cox A, Becker P, Zeuschner P, Zengerling F, Erdmann K, Buerk BT, Kalogirou C, Flegar L. Cano Garcia C, et al. Among authors: ellinger j. Clin Genitourin Cancer. 2024 Aug;22(4):102112. doi: 10.1016/j.clgc.2024.102112. Epub 2024 May 4. Clin Genitourin Cancer. 2024. PMID: 38825563 Free article.
288 results